GL Pharm Tech Corp. (KOSDAQ:204840)
South Korea flag South Korea · Delayed Price · Currency is KRW
814.00
+1.00 (0.12%)
At close: Jul 16, 2026

GL Pharm Tech Cash Flow Statement

Millions KRW. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-131.5812.49-2,337-3,749-790.17-3,727
Depreciation & Amortization
889.681,0021,7102,1382,1452,040
Loss (Gain) From Sale of Assets
---17.5-0.44-1,71424.82
Asset Writedown & Restructuring Costs
-----278.13
Loss (Gain) From Sale of Investments
----12.02-6.85-
Loss (Gain) on Equity Investments
-273.93-279.09-20.1313.13--
Stock-Based Compensation
14.214.2---114.28
Provision & Write-off of Bad Debts
-9.77-8.16-174.4135.19-15.9926.76
Other Operating Activities
15784.93226.9-147.96-742.45470.67
Change in Accounts Receivable
-1,609-1,295-11.43-139.29-2,01915.88
Change in Inventory
-1,111-2,210-1,949-988.09-2,192-579.06
Change in Accounts Payable
233.61507.16-593.43-540.352,481-271.64
Change in Other Net Operating Assets
-833.791,048-1,481-369.331,585-663.83
Operating Cash Flow
-2,735-1,124-4,648-3,760-1,269-2,271
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-3,137-3,203-391.81-579.32-6,438-1,328
Sale of Property, Plant & Equipment
18-18.180.442,0952.95
Sale (Purchase) of Intangibles
-1,219-1,219-1,355--7.02-7.96
Investment in Securities
200.87--26.92-1,000-506.25
Other Investing Activities
107.7247.936.74-12.59-12.61-45.61
Investing Cash Flow
-4,006-4,340-1,580-570.14-5,435-1,897

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
-6,0001,0003,9001,550500
Long-Term Debt Issued
-3,930-5,81010,400-
Total Debt Issued
11,0809,9301,0009,71011,950500
Short-Term Debt Repaid
--2,141-1,917-1,550-1,500-513.3
Long-Term Debt Repaid
--3,822-2,013-4,409-4,453-453.73
Total Debt Repaid
-7,814-5,963-3,930-5,959-5,953-967.03
Net Debt Issued (Repaid)
3,2663,967-2,9303,7515,997-467.03
Issuance of Common Stock
275.55275.559,2807575412.88
Other Financing Activities
-0-000-0.98921.82
Financing Cash Flow
3,5424,2436,3503,8266,071867.67

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-----19.66-
Miscellaneous Cash Flow Adjustments
-0-0---896.680
Net Cash Flow
-3,200-1,222121.95-503.67-1,549-3,301

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-5,871-4,327-5,039-4,339-7,707-3,600
Free Cash Flow Growth
------
Free Cash Flow Margin
-15.93%-12.27%-19.35%-16.67%-46.07%-28.97%
Free Cash Flow Per Share
-75.98-56.10-66.83-69.72-124.25-70.78
Levered Free Cash Flow
-4,655-5,506-4,615-2,672-6,965-2,882
Unlevered Free Cash Flow
-4,264-5,137-4,134-2,183-6,699-2,340

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
586.89573.14777.13788.02382.07349.6
Cash Income Tax Paid
6.87-12.319.24-19.238.1722.53
Change in Working Capital
-3,380-1,950-4,035-2,037-144.54-1,499